MedPath

Phase II trial of capecitabine for brain metastasis of breast cancer

Not Applicable
Conditions
brain metastasis of breast cancer
Registration Number
JPRN-UMIN000001530
Lead Sponsor
ational cancer center hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

The patient have not indication for capecitabine therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath